Literature DB >> 20591297

Permanent inflammatory effect of N-butylcyanoacrylate on vascular wall immunohistochemical analysis.

J Talan-Hranilović1, T Rumboldt, M Vucic, Z Rumboldt, V Beros, V Tonković, V Lupret.   

Abstract

SUMMARY: We report a case with atypical pattern and time course of inflammatory response after partial embolization of a cerebral arteriovenous malformation with N-butylcyanoacrylate (NBCA), examined by immunohistochemical analysis. This pathomorphological finding of permanent acute inflammation has not been previously reported in humans.

Entities:  

Year:  2004        PMID： 20591297      PMCID： PMC3547405          DOI： 10.1177/159101990300900101

Source DB:  PubMed          Journal:  Interv Neuroradiol        ISSN： 1591-0199            Impact factor:   1.610


  11 in total

1.  Treatment-induced neoangiogenesis in cerebral arteriovenous malformations.

Authors:  U Sure; N Butz; A M Siegel; H D Mennel; S Bien; H Bertalanffy
Journal:  Clin Neurol Neurosurg       Date:  2001-04       Impact factor: 1.876

2.  Evidence of increased endothelial cell turnover in brain arteriovenous malformations.

Authors:  T Hashimoto; R Mesa-Tejada; C M Quick; A W Bollen; S Joshi; J Pile-Spellman; M T Lawton; W L Young
Journal:  Neurosurgery       Date:  2001-07       Impact factor: 4.654

3.  Repermeation of partially embolized cerebral arteriovenous malformations: a clinical, radiologic, and histologic study.

Authors:  A Gruber; P R Mazal; G Bavinzski; M Killer; H Budka; B Richling
Journal:  AJNR Am J Neuroradiol       Date:  1996-08       Impact factor: 3.825

4.  Preoperative embolization of arteriovenous malformations with polylene threads: techniques with wing microcatheter and pathologic results.

Authors:  A Benati; A Beltramello; R Colombari; A Maschio; S Perini; R Da Pian; A Pasqualin; R Scienza; L Rosta; E Piovan
Journal:  AJNR Am J Neuroradiol       Date:  1989 May-Jun       Impact factor: 3.825

5.  A clinical and neuropathologic study of silk suture as an embolic agent for brain arteriovenous malformations.

Authors:  J P Deveikis; H J Manz; A J Luessenhop; A J Caputy; A I Kobrine; D Schellinger; N Patronas
Journal:  AJNR Am J Neuroradiol       Date:  1994-02       Impact factor: 3.825

6.  Histopathologic effects of transarterial bucrylate occlusion of intracerebral arteries in mongrel dogs.

Authors:  K K Kish; S M Rapp; H I Wilner; D Wolfe; L M Thomas; J Barr
Journal:  AJNR Am J Neuroradiol       Date:  1983 May-Jun       Impact factor: 3.825

7.  Nonadhesive liquid embolic agent for cerebral arteriovenous malformations: preliminary histopathological studies in swine rete mirabile.

Authors:  Y Murayama; F Viñuela; A Ulhoa; Y Akiba; G R Duckwiler; Y P Gobin; H V Vinters; R J Greff
Journal:  Neurosurgery       Date:  1998-11       Impact factor: 4.654

8.  Long-term pathological follow-up of cerebral arteriovenous malformations treated by embolization with bucrylate.

Authors:  H V Vinters; M J Lundie; J C Kaufmann
Journal:  N Engl J Med       Date:  1986-02-20       Impact factor: 91.245

9.  Histologic analysis of tissue response to bucrylate-pantopaque mixture.

Authors:  L D Cromwell; P C Freeny; C W Kerber; L L Kunz; A B Harris; C M Shaw
Journal:  AJR Am J Roentgenol       Date:  1986-09       Impact factor: 3.959

10.  The pathology of arteriovenous malformations of the brain treated by embolotherapy. II. Results of embolization with multiple agents.

Authors:  J S Schweitzer; B S Chang; P Madsen; F Viñuela; N A Martin; C E Marroquin; H V Vinters
Journal:  Neuroradiology       Date:  1993       Impact factor: 2.804
View more
  1 in total

1.  De novo intracranial arteriovenous malformation development after endovascular treatment for a pial arteriovenous fistula in capillary malformation-arteriovenous malformation syndrome.

Authors:  Bikei Ryu; Shinsuke Sato; Tatsuki Mochizuki; Tatsuya Inoue; Yoshikazu Okada; Yasunari Niimi
Journal:  Interv Neuroradiol       Date:  2020-07-07       Impact factor: 1.610
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.